As of 2026-10-09, the EV/EBITDA ratio of Moderna Inc (MRNA) is -27.56. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNA's latest enterprise value is 77,072.63 mil USD. MRNA's TTM EBITDA according to its financial statements is -2,797.00 mil USD. Dividing these 2 quantities gives us the above MRNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.6x - 13.8x | 13.0x |
| Forward P/E multiples | 11.1x - 14.7x | 13.0x |
| Fair Price | (79.15) - (94.24) | (89.23) |
| Upside | -140.2% - -147.8% | -145.3% |
| Date | EV/EBITDA |
| 2026-10-07 | -27.48 |
| 2026-10-06 | -26.20 |
| 2026-10-05 | -28.44 |
| 2026-10-02 | -26.56 |
| 2026-10-01 | -26.41 |
| 2026-09-30 | -26.93 |
| 2026-09-29 | -28.47 |
| 2026-09-28 | -27.60 |
| 2026-09-25 | -27.82 |
| 2026-09-24 | -27.25 |
| 2026-09-23 | -25.44 |
| 2026-09-22 | -25.51 |
| 2026-09-21 | -24.14 |
| 2026-09-18 | -21.46 |
| 2026-09-17 | -22.03 |
| 2026-09-16 | -20.27 |
| 2026-09-15 | -20.00 |
| 2026-09-14 | -20.42 |
| 2026-09-11 | -20.03 |
| 2026-09-10 | -18.99 |
| 2026-09-09 | -18.85 |
| 2026-09-08 | -19.52 |
| 2026-09-04 | -20.26 |
| 2026-09-03 | -20.73 |
| 2026-09-02 | -21.00 |
| 2026-09-01 | -21.49 |
| 2026-08-31 | -19.52 |
| 2026-08-28 | -19.18 |
| 2026-08-27 | -19.86 |
| 2026-08-26 | -20.84 |
| 2026-08-25 | -22.14 |
| 2026-08-24 | -19.31 |
| 2026-08-21 | -20.20 |
| 2026-08-20 | -18.52 |
| 2026-08-19 | -24.35 |
| 2026-08-18 | -8.54 |
| 2026-08-17 | -8.75 |
| 2026-08-14 | -8.59 |
| 2026-08-13 | -8.64 |
| 2026-08-12 | -8.64 |
| 2026-08-11 | -8.20 |
| 2026-08-10 | -8.09 |
| 2026-08-07 | -8.00 |
| 2026-08-06 | -7.25 |
| 2026-08-05 | -7.59 |
| 2026-08-04 | -7.69 |
| 2026-08-03 | -7.43 |
| 2026-07-31 | -7.39 |
| 2026-07-30 | -7.83 |
| 2026-07-29 | -7.34 |